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Abstract
Background: Gq is a heterotrimeric G protein that plays an important role in numerous physiological processes. To
delineate the molecular mechanisms and kinetics of signalling through this protein, its activation should be
measurable in single living cells. Recently, fluorescence resonance energy transfer (FRET) sensors have been
developed for this purpose.
Results: In this paper, we describe the development of an improved FRET-based Gq activity sensor that consists of
a yellow fluorescent protein (YFP)-tagged Gg2 subunit and a Gaq subunit with an inserted monomeric Turquoise
(mTurquoise), the best cyan fluorescent protein variant currently available. This sensor enabled us to determine, for
the first time, the kon (2/s) of Gq activation. In addition, we found that the guanine nucleotide exchange factor
p63RhoGEF has a profound effect on the number of Gq proteins that become active upon stimulation of
endogenous histamine H1 receptors. The sensor was also used to measure ligand-independent activation of the
histamine H1 receptor (H1R) upon addition of a hypotonic stimulus.
Conclusions: Our observations reveal that the application of a truncated mTurquoise as donor and a YFP-tagged
Gg2 as acceptor in FRET-based Gq activity sensors substantially improves their dynamic range. This optimization
enables the real-time single cell quantification of Gq signalling dynamics, the influence of accessory proteins and
allows future drug screening applications by virtue of its sensitivity.
Background
Heterotrimeric G proteins are composed of Ga subunits
and Gbg dimers, and can be activated by G-protein-
coupled receptors (GPCRs). Upon binding of an agonist,
the receptor changes its conformation, and acts as a
g u a n i n en u c l e o t i d ee x c h a n g ef a c t o r( G E F ) .B yi n d u c i n g
the exchange of guanine diphosphate (GDP) for guanine
triphosphate (GTP) in the Ga subunit, the G protein
becomes active [1]. Gbg interacts with Ga through two
interfaces: the switch region and the region formed by
the N terminus of the Ga subunit. Binding of GTP
upon receptor activation disrupts the switch interface,
which is thought to trigger the dissociation of Gbg from
Ga [2]. The family of Ga subunits consists of four
classes; the subunits Gaq, Ga11, Ga14 and Ga16
belong to the Gq class. The principal target of the Gq
class is phospholipase (PL)Cb [3]. Recently, RhoGEF
proteins such as leukemia-associated Rho-guanine
nucleotide exchange factor (LARG) and p63RhoGEF
have been shown to directly interact with and to be
regulated by Gaq, suggesting that they can link Gaq-
coupled receptors to the activation of the small G pro-
tein RhoA [4-6].
Studying Gaq is important, because this protein is
implicated in the development of myocardial hypertro-
phy after mechanical stress of the heart [7,8]. Because
this is one of the triggers of cardiac failure, a leading
cause of death in the western world, drugs to inhibit
Gaq are much in demand [9]. Proteins belonging to the
Gq class are also involved in the modulation of synaptic
transmission [10,11], cell growth, platelet aggregation
[12], glucose secretion, actin cytoskeletal rearrange-
ments, hematopoietic cell differentiation, leukocyte acti-
vation and contraction of smooth muscle, emphasizing
their importance in human physiology [13].
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fer (FRET) sensors have been developed to monitor the
activation state of specific heterotrimeric G proteins in
living cells upon GPCR activation [14-21]. In this paper,
we report on the development of a highly sensitive sen-
sor based on functional mTurquoise-tagged Gaqa n d
yellow fluorescent protein (YFP)-tagged Gg2, which
allows for monitoring of the location and G protein acti-
vation state of Gq in living cells and of the kinetics of
the process. In addition, we describe the effects of
ligand-dependent and ligand-independent stimulation of
endogenous and overexpressed receptors, while concur-
rently monitoring the influence of effectors on the beha-
viour of the sensor. We opted for dual emission
ratiometric FRET measurements supplemented with
FRET-fluorescence lifetime imaging microscopy (FLIM)
measurements to monitor the kinetics of Gq activation
and FRET efficiencies, respectively.
Results
Construction of a Gq FRET sensor
To further our understanding of the kinetics of Gq sig-
nalling in living cells, we prepared visible fluorescent
protein (VFP)-tagged human Gaq subunits. Because
neither N- nor C-terminal fusions of Gast oV F P
retained functionality [22,23], we opted for insertion of
the fluorescent protein. The VFP insertion site was
based on a Gaq tagged with hemagglutinin (HA) in the
a-helical domain (residues 125-ENPYVD-130 replaced
by DVPDYA [24,25]) and on green fluorescent protein
tagged Gaq( G aq-GFP), as described previously [26].
Monomeric (by applying the A206K mutation [27]) YFP
(mYFP) was inserted into the aB-aC loop of the Gaq
subunit (see Methods section for more details). Upon
transient expression, the protein was found at the
plasma membrane, as judged from the fluorescence pat-
tern seen in HeLa cells (Figure 1A). Fluorescence was
also, to variable extents, detected in the cytoplasm and
occasionally in the nucleus. In various other cell lines
(Madin-Darby canine kidney (MDCK), N1E-115 neuro-
blastoma and HEK293) a similar pattern was seen (see
Additional file 1A-C). The localization pattern of Gaq-
GFP has been thoroughly described by Berlot and col-
leagues [26], and is comparable with the Gaq-mYFP
variant reported here.
FRET, which is a distance- and conformation-depen-
dent phenomenon, is very useful for the study of
dynamic protein interactions in living cells [28]. To
measure FRET, various techniques can be used. To
investigate the kinetics of the interaction between Gaq
and the Gbg dimer, FRET ratio imaging with a cyan
fluorescent protein (CFP)-YFP pair was the method cho-
sen. Ratiometric imaging is an intensity-based technique
to analyze FRET, which involves measurement of the
ratio between donor and acceptor fluorescence intensity
after induction of signal transduction [29]. Recently, we
reported a novel bright CFP variant, monomeric Tur-
quoise (mTq), which has excellent properties for use in
FRET imaging. This fluorescent protein is a monomeric
CFP variant that is twice as bright as enhanced (E)CFP,
is more photostable, displays an improved signal:noise
ratio for ratiometric FRET measurements, has a long
fluorescent lifetime, and decays mono-exponentially
[30]. Therefore, we replaced the mYFP with mTq in the
Gaq-mYFP construct to use it as a donor in FRET
studies.
Since mTq is inserted and the N and C termini of
m T qa r eo nt h es a m es i d eo ft h eb-barrel, we reasoned
that a C-terminal deletion of six amino acids (mTqΔ6,
yielding a fluorescent mTq as in yellow cameleon [31])
would effectively bend the mTq moiety in Gaq, thereby
forcing the mTq fluorophore (and its dipole moment) in
another orientation. This could have a profound effect
on the FRET efficiency (via the 
2 orientation factor,
[28]). Importantly, this variant was also found at the
plasma membrane in HeLa cells, similar to Gaq-mYFP
(see Additional file 1D).
W ec h o s et ot a gt h eNt e r m i n u so fG g2w i t hY F P ,t o
effectively label the Gbg dimer with an acceptor, as this
fusion has previously been shown to retain functionality
[32].
Functionality of the Gq sensor
The functionality of the fluorescent Gaq proteins (Gaq-
mYFP and Gaq-mTqΔ6) was tested in a mouse embryo-
nic fibroblast (MEF) cell line prepared from Gaq/11-
deficient mice [33]. This cell line (MEFq/11
-/-)a n da
MEF cell line prepared from wild-type mice express the
bradykinin (BK) type 2 receptor that couples to Gaq
[34]. As expected, addition of BK (1 μmol/l) led to an
increase in cytosolic calcium in the wild-type MEF cell
line (Figure 1B), but not in the MEFq/11
-/- cell line (Fig-
ure 1C). Expression of wild-type Gaq (Figure 1D), Gaq-
mYFP (Figure 1E) or Gaq-mTqΔ6 (Figure 1F) in MEFq/
11
-/- cells caused an increase in cytosolic calcium upon
addition of BK. These results indicate that Gaq-mYFP
and Gaq- mTqΔ6 can substitute for the wild-type Gaq
in living cells devoid of endogenous Gaq/11 proteins.
Using western blot analysis (see Additional file 2), we
compared the expression level of endogenous Gaq/11 in
MEF cells from wild-type mice with that of Gaq-mYFP
transduced into MEFq/11
-/-.G aq-mYFP in MEFq/11
-/-
was clearly less abundant than Gaq/11 in wild-type
MEF cells, indicating that the observed calcium
responses are not simply due to overexpression.
Correct localization of the heterotrimer requires
cotransfection of the three subunits, as described pre-
v i o u s l y[ 3 5 ] .T oe x a m i n ew h e t h e rG aq-mTq forms a
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Page 2 of 14Figure 1 Gaq-visible fluorescent protein (VFP) is functional. (A) HeLa cells expressing Gaq tagged with monomeric yellow fluorescent
protein (Gaq-mYFP). (B) Mouse embryonic fibroblasts (MEFs) derived from wild-type mice showed an increase in [Ca
2+]i upon addition (arrow)
of bradykinin (BK) (1 μmol/l, n = 6. Error bars depict SE). (C) MEFs derived from Gaq/11-deficient mice (MEFq/11
-/-) did not display increased [Ca
2
+]i upon addition of BK (n = 9). (D) Expression of wild-type Gaq in MEFq/11
-/- caused an increase in cytosolic calcium upon addition of BK (n =
2). Most cells did not express the re-introduced wild-type (untagged) Gaq and did not show a decrease in Fura Red intensity upon addition of
BK. (E) Expression of Gaq-mYFP in MEFq/11
-/- caused an increase in cytosolic calcium upon addition of BK (n = 12); (Inset) MEFq/11
-/- cell
expressing Gaq-mYFP. (F) Gaq-mTqΔ6 similarly caused an increase in [Ca
2+]i upon addition of BK (n = 6). (Inset) MEFq/11
-/- cell expressing Gaq-
mTqΔ6.
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Page 3 of 14heterotrimer with the YFP-tagged Gbg dimer, steady-
state FRET efficiencies were measured in cells coexpres-
sing Gaq-mTq and YFP-Gg2. The truncated version,
Gaq-mTqΔ6, displayed a higher basal FRET level (FRET
efficiency 26%; see also Figure 6) in the presence of
YFP-Gg2, compared with the non-truncated form (FRET
efficiency 18%; data not shown) and was therefore used
in Gq activation measurements.
Dynamic range of the Gq sensor
During the course of our studies, Jensen et al. [19] pub-
lished data on Gq activation using FRET ratio imaging
with Gaq-ECFP and EYFP-Gb1. We compared the
expression of Gaq-ECFP with that of Gaq-mTqΔ6b y
transfecting cells with similar quantities of DNA. Cells
expressing Gaq-mTqΔ6 were readily visible, whereas
cells expressing Gaq-ECFP were substantially less fluor-
escent (see Additional file 3).
To determine the dynamic range of our Gq activity
sensor, we overexpressed the histamine H1 receptor
(H1R) in HeLa cells, and compared the amplitude of the
ratio change of our and the previously described sensor
[19] under identical conditions (Figure 2A,B). We exam-
ined the expression of H1R and Gaq-mTqΔ6u n d e r
these conditions. Binding studies with a radiolabeled
ligand revealed 710 fmol/mg binding sites, which is
about fivefold higher than that of wild-type levels (150
fmol/mg for mock-transfected HeLa cells). Western
blotting (see Additional file 2) indicated that Gaq-
mTqΔ6 was expressed at a level equal to the endogen-
ous Gaq protein.
Addition of histamine caused intensity changes with
much larger amplitudes (about twice as high) in our
Gq sensor. The intensity traces unequivocally showed
that, upon stimulation, the intensity of the donor
(mTq) increased, whereas the sensitized emission of
the acceptor (YFP) decreased (Figure 2A, inset), indi-
cating a loss of FRET and reflecting an increase in dis-
tance between the aB-aC loop of Gaqa n dt h eN
terminus of Gg2 ,o rac h a n g ei no r i e n t a t i o n .T h e s e
clear, reciprocal changes in CFP and YFP intensities
were not seen for the other sensor under identical cir-
cumstances (Figure 2B, inset). The results confirm the
improved fluorescence properties of mTurquoise [30]
and the benefits of deleting the six C-terminal amino
acids of this tag.
Addition of the H1R inverse agonist mepyramine
[36-38] readily caused deactivation (Figure 2; see Addi-
tional file 4). Under H1R overexpression conditions and
in the continued presence of histamine in the medium,
activation of Gq remained unaltered for at least 8 min-
utes (see Additional file 5). Similar changes were seen
upon overexpression of the BK receptor type 2 (data not
shown).
To ascertain the effect of using YFP-Gg2 as acceptor
instead of EYFP-Gb1, we determined the FRET change
in cells coexpressing Gaq-mTqΔ6a n dE Y F P - G b1( F i g -
ure 2C). Using EYFP-Gb1 as acceptor clearly diminished
the amplitude of the response, indicating that the use of
YFP-Gg2 as an acceptor increases the sensitivity of the
sensor. When Gaq-ECFP was used together with the
acceptor YFP-Gg2 ,am o r er o b u s tF R E Tc h a n g ew a s
seen (compare Figure 2D with 2B). In summary, these
data show that the combination of Gaq-mTqΔ6a n d
YFP-Gg2 significantly improve the response of the Gq
activity sensor.
To investigate the sensitivity of our sensor (Gaq-
mTqΔ6/YFP-Gg2), we overexpressed H1R and tested
the response of the sensor to a range of agonist concen-
trations (Figure 3). Interestingly, a transient FRET
change was seen upon stimulation with 0.1 μmol/l hista-
mine, whereas its duration was prolonged upon addition
of higher amounts of histamine. It seems that the
amount of active Gq accumulates progressively every
time the total concentration of histamine is increased,
and that concomitantly, active Gq is desensitized less
efficiently at each new histamine addition.
Kinetics of Gq activation
An important parameter describing the Gq activation
kinetics is its activation rate (kon) upon receptor activa-
tion. To date, no conclusive data has been produced to
quantify this kinetic parameter. By monitoring the FRET
change kinetics of the FRET pair (Gaq- mTqΔ6a n d
YFP-Gg2) upon addition of histamine, we were able to
determine the activation kinetics of the heterotrimer.
Activation of Gq was too fast to be measured by our
widefield set-up (which used sequential CFP/YFP acqui-
sition), therefore the experiments were repeated using a
laser-scanning microscope with a resonant scanner.
With this, it was possible to perform ratio imaging of
FRET with a frame rate of around 15 frames/s, which
provided sufficient temporal resolution to measure the
kinetics of Gaq activation by H1 receptors (Figure 4A).
The activation kinetics was appropriately fitted using a
monoexponential curve, yielding a half-time for activa-
tion of 350 ms (Figure 4B), implying that kon = 2/s.
Influence of accessory proteins on the activation state of
Gq
Besides studying activation kinetics under receptor over-
expression conditions, we were interested in obtaining
data in the absence of overexpressed receptors. Stimula-
tion of the endogenous [39] histamine receptor type 1
(H1R) in HeLa cells by addition of histamine also led to
a measurable FRET decrease (Figure 5A), but with
markedly different kinetics. Because Ga subunits cycle
between their inactive (GDP-bound) and active (GTP-
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Page 4 of 14bound) states, the duration of the active state is limited
by its intrinsic GTP hydrolysis and GTP-ase activating
protein (GAP) activity executed by accessory proteins.
Remarkably, even in the continuous presence of agonist,
the activation state of Gq is partially desensitized (Figure
5A), contrary to reports for Gai [16] and Gas( a l b e i ti n
the presence of overexpressed receptors) [17]. Clearly,
under H1R overexpression conditions (Figure 2A; Figure
5B; see Additional file 5), the activation state of Gq is
prolonged. Gaq can be stimulated to hydrolyze its
Figure 2 Dynamic range of Gq sensors. (A) The fluorescence resonance energy transfer (FRET) ratio change (yellow fluorescent protein:
monomeric Turquoise (YFP:mTq)) upon addition of histamine (100 μmol/l) in HeLa cells coexpressing Gaq-mTqΔ6, Gb1, YFP-Gg2 and the
histamine H1 receptor (H1R) (Inset) the mTq and YFP intensity traces from which the ratio was derived (n = 14; error bars depict SE). Addition of
the H1R inverse agonist mepyramine (10 μmol/l) reversed the ratio change induced by histamine. (B) The FRET ratio change (YFP:CFP) upon
addition of histamine (100 μmol/l) in HeLa cells coexpressing Gaq-enhanced (E)CFP, EYFP-Gb1, Gg2 and H1R. (Inset) the CFP and YFP intensity
traces from which the YFP:CFP ratio was derived (n = 17; error bars depict SE). (C) Representative trace of the FRET ratio change (YFP:mTq) upon
addition of histamine (100 μmol/l) in HeLa cells coexpressing Gaq- mTqΔ6, EYFP-Gb1, Gg2 and H1R. (Inset). The mTq and YFP intensity traces
from which the ratio was derived. (D) The FRET ratio change (YFP:CFP) upon addition of histamine (100 μmol/l) in HeLa cells coexpressing Gaq-
ECFP, Gb1, YFP-Gg2 and H1R. (Inset) the CFP and YFP intensity traces from which the ratio was derived (n = 5; error bars depict SE).
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(RGS) proteins and phospholipase (PL)Cb isozymes
[40,41]. To test the role of RGS proteins in desensitiza-
tion of active Gq, an RGS-insensitive Gaq-mTqΔ6w a s
constructed by mutating G188 in switch I into S188. This
mutation has been shown to inhibit binding of RGS pro-
teins to Gaq ([42] and references therein), while leaving
the intrinsic rate of GTP hydrolysis unchanged. FRET
measurements using Gaq-mTqΔ6-G188S and YFP-Gg2
show that the onset of Gq activation is slower. Desensiti-
zation also seems to be compromised, albeit not comple-
tely absent (see Additional file 6).
Next, we studied the influence of the recently
described effector of Gq, p63RhoGEF [5,6,43], on the
activation state of Gq. Strikingly, coexpression of
p63RhoGEF again caused an increase in the observed
ratio changes between Gaq-mTqΔ6a n dY F P - G g2u p o n
addition of histamine (Figure 5C). The decrease in
FRET readily returned to baseline upon addition of
mepyramine (see Additional file 7). Importantly, the
Gaq-interaction mutant p63RhoGEF-L475A [43] did
not induce such an increase (see Additional file 8).
The prolonged FRET response with stimulation in the
presence of p63RhoGEF or overexpressed H1R enabled
us to apply the more quantitative FLIM technique to
measure FRET levels. With FLIM, the excited state life-
time of the donor fluorophores is determined. In the
case of FRET, the excited state duration is shortened
because of transfer of energy to the acceptor [44].
Because fluorescence lifetimes do not depend on local
excitation intensity or fluorophore concentration, and
are largely unaffected by moderate levels of photo-
bleaching of the fluorophores, FLIM is a very robust
method to quantify FRET in living cells [29]. In the case
of frequency-domain FLIM, two lifetimes can be mea-
sured, that is, the phase life t i m ea n dt h em o d u l a t i o n
lifetime, which both decrease in FRET.
The FLIM data revealed a reduction of the mTur-
quoise modulation lifetime (data not shown) and phase
lifetime from 3.4 ns (donor only) to 2.5 ns in the pre-
sence of its acceptor YFP-Gg2 (Figure 6). These lifetimes
correspond to a FRET efficiency of 26%. In the presence
of H1R, similar FRET efficiencies were seen in resting
cells, but upon addition of histamine, the donor lifetime
increased. Similar increases were found by stimulating
cells coexpressing p63RhoGEF with the Gq FRET sen-
sor. These results unequivocally showed a decrease in
FRET in the Gq sensor upon GPCR stimulation (Figure
6; see Additional file 9), corroborating the ratiometric
data.
Ligand-independent activation of H1R activates Gq
Recently, Mederos y Schnitzler et al. [45] reported that
certain GPCRs function as sensors of membrane stretch,
with the H1 receptor being particularly mechanosensi-
tive compared with AT1R, M5R and V1AR. Membrane
Figure 3 Dose-response curve. (A) Representative trace depicting the fluorescence resonance energy transfer (FRET) ratio changes (yellow
fluorescent protein:monomeric Turquoise (YFP:mTq)) upon addition of increasing amounts of histamine (gray bars) in HeLa cells expressing Gaq-
mTqΔ6, Gb1, YFP-Gg2 and the histamine H1 receptor (H1R). (B) The mTq and YFP intensity traces from which the ratio was derived.
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Page 6 of 14stretch can be induced by the application of a hypotonic
stimulus (hypotonic cell swelling). First, we examined
whether hypotonic stimulation of endogenous H1 recep-
tors of HeLa cells could induce Gq activation, and
found that it was not sufficient to produce a measurable
Gq activation, as a ratio change was not seen (Figure
7A). Importantly, the same cells were capable of
responding to histamine (Figure 7A).
Next, we examined whether overexpression of H1
receptors could trigger Gq activation upon application
of a hypotonic stimulus. A clear FRET decrease was
seen in these cells (Figure 7B), indicating Gq activation.
Figure 4 Kinetics of Gq activation. (A) The fluorescence resonance energy transfer (FRET) ratio change (yellow fluorescent protein:monomeric
Turquoise (YFP:mTq)) upon addition of histamine in cells expressing Gaq-mTqΔ6, Gb1, YFP-Gg2 and histamine H1 receptor (H1R), measured with
high temporal resolution. Images were acquired at a frame rate of 0.064 seconds, and 1000 data points are shown. (B) Average FRET ratio
change (scaled between 0 and 1) upon addition of histamine (n = 11; error bars depict SE). The data points were appropriately fitted with a
monoexponential curve (solid line).
Figure 5 Accessory proteins affect the activation state of Gq. (A) endo.: the fluorescence resonance energy transfer (FRET) ratio change
(yellow fluorescent protein:monomeric Turquoise (YFP:mTq)) upon addition (arrow) of histamine (100 μmol/l) in HeLa cells expressing Gaq-
mTqΔ6, Gb1 and YFP-Gg2. (Inset) the mTq and YFP intensity traces that belong to the ratio (n = 9; error bars depict SE). (B) +H1R: the FRET ratio
change (YFP/mTq) upon addition (arrow) of histamine (100 μmol/l) in HeLa cells expressing Gaq-mTqΔ6, Gb1, YFP-Gg2 and histamine H1
receptor (H1R). (Inset) the mTq and YFP intensity traces that belong to the ratio. (C) +p63: the FRET ratio change (YFP/mTq) upon addition of
histamine (100 μmol/l) in HeLa cells expressing Gaq-mTqΔ6, Gb1, YFP-Gg2 and the guanine nucleotide exchange factor p63-RhoGEF. (Inset) the
mTq and YFP intensity traces that belong to the ratio (n = 9).
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mechanosensitive H1R, leading to the activation of Gq.
The activation of Gq, as detected by the decrease in
FRET, led to activation of PLCb. We visualized the
activity of PLC by monitoring the PH domain of PLCδ1
(PHδ1), which specifically binds PtdIns(4,5)P2 [46].
Addition of a hypotonic stimulus caused the PHδ1
domain to translocate from the plasma membrane to
the cytosol, indicative of the hydrolysis of PtdIns(4,5)P2
(see Additional file 10). Consecutive addition of mepyra-
mine did not affect the localization of PHδ1, suggesting
that the activation of H1R by stretch cannot be inhibited
by an antagonist.
Discussion
Characteristics of the Gq FRET sensor
To evaluate functionality, we extensively tested the VFP-
tagged Gq in MEF cells deficient in Gq/11. The results
in these cells showed that Gaq-mTqΔ6 effectively inter-
acts with GPCRs and PLCb (Figure 1). In addition, we
can state that it can also form heterotrimers with Gbg
subunits, because receptors bound Ga subunits poorly
a n df a i l e dt ot r i g g e rG D Pe x c h a n g ei nt h ea b s e n c eo f
Gbg [47]. Moreover, we saw substantial FRET when
Gaq-mTqΔ6 was coexpressed with an YFP-tagged Gg2.
The spatiotemporal characteristics of heterotrimeric G
protein activation are difficult to monitor, because direct
measurement of GTP binding and hydrolysis is not feasi-
ble in living cells [48]. Instead, an increase in intracellular
calcium, measured using calcium-sensitive fluorescent
probes, is often used as an indicator of Gq activity. How-
ever, other heterotrimeric G proteins can cause increases
in intracellular calcium by means of calcium entry from
the extracellular environment, and by activation of PLCb
via Gbg dimers [49-51]. In addition, increases in intracel-
lular calcium triggered by Gq-coupled receptors are
amplified signals that are modulated by downstream fac-
tors (for example, calcium-store depletion and regulation
of effector function by Ca
2+-activated kinases). Hence,
they are not ideal to quantify the extent and dynamics of
G protein activation. The FRET pair described here
enables the direct measurement of heterotrimeric G pro-
tein activation. Through the use of an optimized fluoro-
phore, the bright CFP variant mTurquoise (see
Additional file 3), positioned in an orientation yielding a
higher basal FRET efficiency level in the intact heterotri-
mer, in combination with YFP-Gg2a sa na c c e p t o r ,w e
were able to measure Gq activation kinetics in single
cells with high temporal resolution.
The half-time of Gq activation of 350 ms is faster than
those of Gs and Gi (450 and 690 ms, respectively)
Figure 7 Ligand-independent activation of Gq. (A) Graph
depicting the fluorescence resonance energy transfer (FRET) ratio
(yellow fluorescent protein:monomeric Turquoise (YFP:mTq)) change
upon the application of a hypotonic (Hypo) stimulus, followed by
the addition of histamine (100 μmol/l) in HeLa cells expressing
Gaq-mTqΔ6, Gb1 and YFP-Gg2 (n = 5; error bars depict SE). (B)
HeLa cells overexpressing the H1 receptor showed significant
activation of Gq when the osmolality of the medium was reduced
(Hypo). Subsequent addition of histamine yielded additional
activation of Gq (n = 5).
Figure 6 Fluorescence lifetime data. Average cyan fluorescent
protein (CFP) lifetimes measured under different conditions. The
phase lifetime of Gaq-mTqΔ6 was measured in the absence (n =
15) and presence (n = 12) of the acceptor YFP-Gg2. The difference
in lifetime was significant. The Gq sensor was coexpressed with the
histamine H1 receptor (H1R) and CFP lifetimes were measured
before and after addition of 100 μmol/l histamine (n = 6). The Gq
sensor was coexpressed with the guanine nucleotide exchange
factor p63RhoGEF and CFP lifetimes were measured before and
after addition of 100 μmol/l histamine (n = 6). In both conditions
the lifetime difference before and after stimulation was significant.
The CFP lifetimes before addition of histamine are not different
(Student t-test, 95% CI) in the presence or absence of either H1R or
p63RhoGEF.
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Page 8 of 14(Figure 4) [14,17]. As receptor-G-protein interaction has
been shown to be maximal after about 50 ms for several
GPCR-G-protein pairs [15,17,52], it is likely that the
H1R-Gq interaction displays similar kinetics. Only a few
Gq heterotrimers will be active at this early time point.
Full activation of Gq proteins requires several hundred
milliseconds, making G-protein activation (not receptor
activation, receptor diffusion or receptor-G protein
interaction) a limiting step in GPCR activation of down-
stream effectors. Interestingly, Mukhopadhyay and Ross
[53] described the kinetics of Gq activation in vitro, and
found GTP exchange to be rate-limiting for Gq activa-
tion. However, at cellular GTP levels, the GDP dissocia-
tion rate became rate-limiting. The GDP dissociation
rate was found to be 1.5/s, which correlates well with
the rate of Gq activation determined by means of our
FRET sensor in living cells.
Previous studies with FRET sensors on activation of
other classes of heterotrimeric G proteins showed a sus-
tained activity in the continued presence of agonist
[14-17,19,52]. For example, Gi activation only desensi-
tizes noticeably upon removal of the agonist or addition
of specific antagonists [14,16]. In our study, we also saw
a long-lasting Gq activation in the presence of agonist
when the histamine receptor was overexpressed (see
Additional file 5), but the activation was readily reversed
when an antagonist was added. By contrast, Gq activa-
tion was partially desensitized when endogenous hista-
mine receptors were activated (Figure 5A). Presumably,
this recovery is possible because GAPs are able to con-
vert Gaq-GTP into Gaq-GDP under these conditions.
Indeed, upon introduction of G188S in Gaq-mTqΔ6,
the Gq activation kinetics changed compared with those
of Gaq-mTqΔ6; the response had a slower onset and
prolonged activation (see Additional file 6). Clark and
Lambert also described these phenomena previously
[42]. However, in our case the observed phenotype was
rather weak, which may imply that PLCb is the physio-
logical GAP in our system. Importantly, the dose-
response curve analysis (Figure 3) showed that the
FRET change was also transient at low agonist concen-
trations under conditions in which histamine receptor
was overexpressed. The histamine levels we used are in
the physiological range, that is, whole blood levels were
25-65 ng/ml of histamine [54], corresponding to hista-
mine concentrations in whole blood of 0.22-0.58 μmol/l.
Our data suggest that cells overexpressing H1R may
show a small, transient Gq activation response to these
histamine levels in blood.
Influence of accessory proteins on the activation state of
Gq
Overexpression of p63RhoGEF led to an increase in the
FRET ratio amplitude (Figure 5C), but the Gaq-
interaction mutant, p63RhoGEF-L475A, did not have an
effect on the amplitude (see Additional file 8). It is likely
that p63RhoGEF retains Gq in its active state by shield-
ing it from the GAP PLCb, thereby accumulating Gaq-
GTP.
The question of whether intact heterotrimers or disso-
ciated G-proteins (Gaqa n dG bg) activate downstream
effectors has not been resolved to date, and most of our
knowledge has been obtained from structural studies
with purified proteins. Gaq-GDP and Gbg interact
through two interfaces. The most extensive interface is
formed by residues close to and within switch I and II
from the Ga subunit. These residues contact Gb resi-
dues at the top of the propeller domain. The second
interface is formed by the N terminus of Ga and the
side of the Gb propeller [2,55]. Gb is most severely
affected in binding to Ga when it contains mutations in
the region that interacts with the N terminus of Ga,
indicating that the N terminus is crucial in mediating
the interaction with Gb [56]. It may therefore be envi-
sioned that, upon activation, the contact of Gb with the
s w i t c hr e g i o n si sl o s t ,w h e r e a si t sc o n t a c tw i t ht h eN
terminus remains, as suggested by Gibson and Gilman
[16]. This would enable an opening up of the trimer,
allowing Ga and Gbg to interact with their downstream
signalling partners. However, activation of certain effec-
tors may require complete dissociation of the heterotri-
mer. Accessory proteins may cause dissociation of Gaq
and Gbg by forcing them apart. The recently published
crystal structure of the G protein-coupled receptor
kinase GRK2 in complex with Gaq-GTP and Gbg exem-
plifies this idea [57]. It showed that GRK2 interacts with
Gbg residues implicated in both interfaces, thereby
probably causing trimer dissociation.
The increases in FRET ratio amplitude that we
observed may be due to an increase in fully dissociated
heterotrimers, which causes a loss of FRET. However, a
loss in FRET can also be explained by a change in orien-
tation between donor and acceptor fluorophore via the
k
2 factor in the equation that determines the Förster
radius. Interestingly, even under conditions of maximal
GEF and minimal GAP activity, we detected extensive
FRET (20%) between Gaqa n dG g2, indicating that the
majority of Gaq is still in close proximity to Gg2( o n
average in the order of 7 nm, based on the FRET För-
ster radius). These data would support the partial open-
ing hypothesis as outlined above, implying that full
dissociation does not occur. However, although it indi-
cated that Gq is not fully dissociated under these maxi-
mal stimulation conditions, our method cannot
distinguish between a partial dissociation leaving a frac-
tion of non-dissociated heterotrimers with unaltered
high FRET efficiency (25%) and a full conformational
change of all heterotrimers characterized by a lower
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signalling role for the intact Gq heterotrimer [58].
Ligand-independent activation of H1R activates Gq
Ligand-independent activation of GPCRs is a new and
not yet fully explored phenomenon. It was described by
Mederos y Schnitzler et al. [45] in HEK293 cells and
COS-7 cells overexpressing the histamine H1 receptor,
among others. Conformational changes in GPCR
(FRET-based measurements) upon addition of a hypo-
tonic stimulus and consecutive receptor activation have
been described for BK2R in bovine aortic endothelial
cells [59], for PTH1R (FRET-based) in pre-osteoblastic
cells [60], and for AT1R (determined by means of sub-
stituted cysteine accessibility mapping) in HEK293 cells
[61]. Studying mechanotransduction is especially impor-
tant with respect to its effects on the cardiovascular sys-
tem. For instance, mechanical stress to cardiomyocytes
can trigger hypertrophic responses [62]. Using our Gq
activity sensor, we were able to monitor Gq activation
upon application of a hypotonic stimulus. Overexpres-
sion of H1R was required to observe a ratio change.
Interestingly, we did observe an increase in the ratio
change of the Gq FRET sensor in the presence of endo-
genous H1R upon addition of histamine, after hypotonic
swelling of the cells. This suggests that heterotrimeric G
proteins are triggered to bind the endogenous H1 recep-
tor upon hypotonic stress, which may lead to changes in
orientation of or distance between a small fraction of
trimers. This pre-accumulation at the H1R might
explain the larger amplitude seen upon addition of his-
tamine, compared with that seen without prior exposure
to hypotonic stress (Figure 5A).
Determination of H1R expression levels showed that
in our cells overexpression produced an average of 710
fmol/mg binding sites. Similarly, in A7r5 cells derived
from the aorta (a mechano-insensitive tissue) overex-
pression of the AT1 receptor of about 15 times (88
fmol/mg versus 1305 fmol/mg) induced mechanosensi-
tivity [45]. Moreover, the expression of AT1R in the
aorta has been described to be 5 fmol/mg [63], whereas
it can be up to 200 fmol/mg in the afferent arterioles (a
mechanosensitive tissue) [64].
A conformational change in the AT1 receptor upon
mechanical stress has been described [61]. Currently, it
is not clear how this conformational change is triggered,
and whether all mechanosensitive GPCRs undergo a
similar change in conformation. It is likely that a FRET
approach may shed more light on this matter.
Conclusions
By virtue of the optimized Gq FRET sensor described in
this paper, the activation of Gq can now directly be
measured with high spatial and temporal resolution in
single living cells without having to rely on pharmacolo-
gical inhibitors to delineate the involvement of specific
signalling pathways. As a result we have determined kon
of Gq for the first time. It is likely that FRET-based sen-
sors for the measurement of other classes of G proteins,
which employ ECFP as donor and EYFP-Gb1 as accep-
tor, will be substantially improved by incorporating
(truncated and monomerized) mTurquoise and using
YFP-Gg2 as acceptor.
Inhibitors of G proteins are attractive drug candidates
[47]. The fact that overexpression of the C terminus of
Gaq has a positive effect on cardiac hypertrophy indi-
cates a possible strategy for preventing pathophysiologi-
cal signalling [7]. The FRET pair we developed may aid
in the search for new drugs by facilitating highly sensi-
tive Gq activity measurements in living cells. Moreover,
we have shown that this tool can be used to study the
kinetics of heterotrimeric G protein signalling and the
influence of accessory proteins.
Methods
DNA constructs
The pcDNA3.1+ plasmids containing the cDNA encod-
ing human Gaq, Gb1, Gg2 and H1R were obtained from
the Missouri S&T cDNA Resource Center (http://www.
cdna.org). We inserted monomeric (A206K) spectral var-
iants of GFP in the aB-aCl o o po fG aqi nb e t w e e nr e s i -
dues 127 and 128, thereby changing N126 into D126.
The linkers present in the Gaq-YFP construct are
SGGGGS at the N terminus of the FP and SGGSGD at
the C terminus of the FP. To make the Gaq-mTqΔ6 con-
struct, the last six amino acids of mTq were removed.
The linkers present in this construct are SGGGGS at the
N terminus of the FP and I at the C terminus of the FP.
Gaq-YFP was amplified by means of PCR and inserted
into the retroviral vector pBABE-puromycin (Addgene
Inc, Cambridge, MA, USA). Detailed sequence informa-
tion of the construct is available upon request.
To make YFP-Gg2, we amplified Gg2 by means of
PCR and cloned it behind circular-permutated Venus
derived from YCam3.60 [65] (kind gift of Dr A Miya-
waki, Riken, Wako, Japan). The full-length p63RhoGEF
was a gift from Dr J Sondek (University of North Caro-
l i n a ,C h a p e lH i l l ,N C ,U S A ) ;G aq-ECFP was provided
by Dr C. Berlot (Weis Center for Research, Danville,
PA, USA)and EYFP-Gb1 by Dr S Ikeda (National Insti-
tutes of Health, Bethesda, MD, USA). Gaq-ECFP was
transferred from pcDNAI to a high copy number plas-
mid by replacing EGFP in the pEGFP-C1 plasmid, using
the restriction enzymes SnaBI and PspOMI.
Cell culture and transfection/transduction
All cell culture media were from Invitrogen (Breda, The
Netherlands). MEF cells devoid of Gaq/11 subunits
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in Dulbecco’s modified Eagle’sm e d i u m( D M E M )
(#21969-035)] supplied with 1× non-essential amino
acids, 10% fetal bovine serum (FBS), 1× L-glutamine,
100 U/ml penicillin and 100 μg/ml streptomycin. For
transduction of these cells, the retroviral vector pBABE-
Gaq-YFP was transfected into Phoenix-Eco package
cells, and the supernatant, containing viral particles, was
harvested 48 hours after infection. Cells were incubated
with 1 ml of this supernatant in the presence of 10 μl
Dotap (1 mg/ml) (Roche, Indianapolis, IN, USA) and
after 48 hours, cells were grown for 2 weeks on media
containing 2 μg/ml puromycin for selection. For ima-
ging, these cells were cultured on glass coverslips and
loaded with the calcium indicator Fura Red (6 μg/ml
final concentration) (Fura Red AM; Molecular Probes,
Eugene, OR, USA) for 30 minutes at room temperature.
For imaging, non-transduced MEF cells were cultured
on glass coverslips and transfected (Lipofectamine
reagent; Invitrogen) with plasmids encoding Gaq-
mTqΔ6. After overnight incubation at 37°C and 5%
CO2, the cells were loaded with Fura Red and mounted
in a cell chamber (Attofluor; Invitrogen), submerged in
medium (140 mmol/l NaCl, 5 mmol/l KCl, 1 mmol/l
MgCl2, 1 mmol/l CaCl2, 10 mmol/l glucose, 20 mmol/l
HEPES pH 7.4) and viewed under a confocal
microscope.
HeLa cells (American Tissue Culture Collection; Man-
assas, VA, USA) were cultured in DMEM plus Glutamax
(#61965-059), 10% FBS, 100 U/ml penicillin and 100 μg/
ml streptomycin. Transfection and preparation for ima-
ging purposes were similar to the procedures described
above for MEF cells.
Confocal microscopy
Mammalian cells were imaged using a confocal laser-
scanning microscope (LSM 510; Carl Zeiss GmbH,
Oberkochen, Germany) with an oil-immersion objective
(Plan-A 63×/1.4; Carl Zeiss GmbH). Samples were
excited with a 488-nm argon laser. For YFP/Fura Red,
the following settings were used a primary dichroic mir-
ror (488 nm) and a secondary dichroic mirror (570 nm),
thereby splitting the Fura Red fluorescence from the
YFP fluorescence. The 505 to 550 nm bandpass filter
was used to yield the YFP image, and the long-pass 650
nm filter was used to obtain the Fura Red image. MEF
cells were stimulated with 1 μmol/l (final concentration)
BK (Sigma-Aldrich, St. Louis, MO, USA), and the Fura
Red intensity was followed in time as a measure of
intracellular calcium levels. The n determinations are
derived from different cells, expressing different
amounts of protein from the same batch of MEF cells
on different days, and throughout the study, cells from
different experiments were pooled and are displayed as
n determinations.
Fast imaging was performed on a confocal microscope
(A1; Nikon, Tokyo, Japan). The excitation light was
from a 443-nm laser, which was reflected onto the sam-
ple by a 457/514 dichroic mirror. Fluorescence emission
was separated by a secondary dichroic mirror (515 nm).
mTq fluorescence was filtered through a 464 to 499 nm
emission filter, and sensitized emission was filtered
through a 525 to 555 nm emission filter. A 40× objec-
tive was used, and the pinhole was completely opened.
The frame size was 512 × 128 pixels, and images were
acquired at 15 frames per second (60 frames/s with four
line averages). The curve was fitted using
y = (1 − exp(−kon × t)).
The half-time of the first-order reaction is given by:
t1/2 =l n ( 2 ) / k on.
Wide-field fluorescence microscopy
Ratiometric FRET measurements in HeLa cells were
performed using a wide-field fluorescence microscope
(Axiovert 200 M; Carl Zeiss GmbH) kept at 37°C,
equipped with an oil-immersion objective (Plan-Neo-
fluar 40×/1.30; Carl Zeiss GmbH) and a xenon arc lamp
with monochromator (Cairn Research, Faversham, Kent,
UK). Images were recorded with a cooled charged-
coupled device camera (Coolsnap HQ, Roper Scientific,
Tucson, AZ, USA). Fluorophores were excited with 420
nm light (slit width 30 nm), mTq emission was detected
with the bandpass 470/30 filter, and YFP emission was
detected with the BP535/30 filter by turning the filter
w h e e l .T h ee x p o s u r et i m ef o re a c hi m a g ew a s2 0 0m s .
HeLa cells were stimulated with 100 μm o l / l( f i n a lc o n -
centration) histamine (Sigma-Aldrich) and mTq/YFP
emission was followed in time. Pyrilamine (mepyramine)
(Sigma-Aldrich) was added to obtain a final concentra-
tion of 10 μmol/l.
Fluorescence lifetime imaging microscopy
Frequency-domain FLIM measurements were performed
using the apparatus described previously [66], equipped
with an oil-immersion objective (Plan Apochromat 63×/
1.4 objective; Carl Zeiss GmbH). Samples were excited
by means of a 442 nm helium-cadmium laser modulated
at 75.1 MHz and a BP 480/40 emission filter was used
to detect mTq fluorescence. FLIM stacks of 24 phase
images permutated in recording order [67] were
acquired with an exposure time of about 0.1 to 0.5 sec-
onds each. FRET efficiency was calculated as follows:
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where τDA and τD are the donor lifetimes in the pre-
sence and absence of an acceptor, respectively.
Membrane stretch
A hypotonic stimulus was applied by replacing 0.5 ml
medium by 20 mmol/l HEPES pH 7.4.
WB
The antibody against Gaq/11 (sc-46972, C-16; Santa
Cruz Biochemicals, Santa Cruz, CA, USA) was directed
against an epitope near the C terminus.
H1R expression level determination
HeLa cells were scraped from a 90 mm petri dish, and
resuspended in binding buffer (50 mmol/l Na2/K-phos-
phate buffer pH 7.4), and mixed by sonication to ensure
a homogenous membrane suspension. The membrane
suspension was added to premixed radioligand/competi-
tor or radioligand/buffer solutions, and incubated for
approximately 1 hour at room temperature on a shaking
table (750 rpm). Free radioligand was separated from
bound radioligand by filtration through a GF/C filter-
plate (PerkinElmer Corp., Waltham, MA, USA) pre-
soaked with 0.5% polyethyleneimine. Scintillation fluid
was added to the filter plate, and radioactivity was mea-
sured in a Wallac micro b counter. Each well contained
25 μl competitor (final concentration: 10 μmol/l mian-
serin) or binding buffer, 25 μl radioligand (25.8 Ci/
mmol [
3H]-mepyramine) and 50 μl membrane
suspension.
Additional material
Additional File 1: Gaq-monomeric visible fluorescent protein
(mVFP) expression in various cell lines (A) Madin-Darby canine kidney
(MDCK) cells expressing Gaq-monomeric yellow fluorescent protein
(mYFP); (B) N1E-115 neuroblastoma cells expressing Gaq-mYFP; (C)
HEK293 cells expressing Gaq-mYFP; (D) HeLa cells expressing Gaq-
mTqΔ6.
Additional File 2: Expression of Gaq in mouse embryonic
fibroblasts (MEF) and HeLa cell lines Transfected, transduced or
untreated cells were treated with trypsin and lysed. Each lane was
loaded with 40 μg of protein. Western blotting was performed with an
antibody against Gaq/11 (diluted 1:1000) and exposed for 30 seconds.
Lane 1 contains wild-type HeLa cells; lane 2 contains HeLa cells
transfected with Gaq-mTqΔ6; lane 3 contains MEFq/11
-/- cells; lane 4
contains MEFq/11
-/- cells transduced with Gaq-mYFP and lane 5 contains
wild-type MEF cells.
Additional File 3: Expression of Gaq-monomeric Turquoise (mTq)Δ6
versus Gaq-enhanced cyan fluorescent protein (ECFP) in HeLa cells
Representative images of HeLa cells expressing Gaq-ECFP (top) or Gaq-
mTqΔ6 (bottom), 2 days after transfection with equal amounts of DNA.
The images were acquired with the same exposure time and contrast
settings.
Additional File 4: Gq fluorescence resonance energy transfer (FRET)
movie Movie displaying the change in FRET ratio upon addition of
histamine (100 μmol/l), followed by the addition of mepyramine (10
μmol/l) in HeLa cells expressing Gaq-monomeric Turquoise (mTq)Δ6,
Gb1, yellow fluorescent protein (YFP)-Gg2 and histamine 1 receptor
(H1R).
Additional File 5: Long-term activation of Gq Graph depicting the
duration of the change in fluorescence resonance energy transfer (FRET)
ratio (yellow fluorescent protein:monomeric Turquoise (YFP:mTq)) in the
continuous presence of histamine in HeLa cells expressing Gaq-
monomeric Turquoise (mTq)Δ6, Gb1, YFP-Gg2 and histamine 1 receptor
(H1R).
Additional File 6: Regulators of G-protein signalling (RGS)-sensitive
versus RGS-insensitive Gq (A) The fluorescence resonance energy
transfer (FRET) ratio change (yellow fluorescent protein:monomeric
Turquoise (YFP:mTq)) upon addition of histamine (100 μmol/l) in HeLa
cells expressing Gaq-mTqΔ6, Gb1 and YFP-Gg2 (n = 4; error bars depict
SE). (B) The FRET ratio change (YFP:mTq) upon addition of histamine
(100 μmol/l) in HeLa cells expressing Gaq-mTqΔ6-G188S, Gb1 and YFP-
Gg2 (n = 8).
Additional File 7: Effect of mepyramine on Gq fluorescence
resonance energy transfer (FRET) ratio changes in the presence of
the guanine nucleotide exchange factor p63RhoGEF Representative
trace depicting the FRET ratio change (yellow fluorescent protein:
monomeric Turquoise (YFP:mTq)) upon addition of histamine (100 μmol/
l) in HeLa cells coexpressing Gaq-mTqΔ6, Gb1, YFP-Gg2 and p63RhoGEF.
Addition of the histamine 1 receptor (H1R) inverse agonist mepyramine
(10 μmol/l) reversed the ratio change induced by histamine. (Inset) the
mTq and YFP intensity traces from which the ratio was derived.
Additional File 8: Overview of observed fluorescence resonance
energy transfer (FRET) ratio changes Histogram depicting the
normalized FRET ratio (yellow fluorescent protein:monomeric Turquoise
(YFP:mTq)) changes upon histamine stimulation, observed in cells
expressing Gaq-mTqΔ6, Gb1 and YFP-Gg2 (wild-type (wt); n = 54); cells
expressing Gaq-mTqΔ6, Gb1, YFP-Gg2 and histamine 1 receptor (H1R, n
= 8); cells expressing Gaq-mTqΔ6, Gb1, YFP-Gg2 and the guanine
nucleotide exchange factor p63RhoGEF (p63, n = 29); cells expressing
Gaq-mTqΔ6, Gb1, YFP-Gg2 and p63RhoGEF-L475A (p63LA, n = 15). The
error bars depict SE.
Additional File 9: Lifetime data (A) Gaq-monomeric Turquoise (mTq)
Δ6 intensity (C) and phase lifetime image in the absence of acceptor
(yellow fluorescent protein) YFP-Gg2. (B) Gaq-mTqΔ6 intensity and (D)
phase lifetime image in the presence of acceptor YFP-Gg2. (E) Phase
lifetime histogram; lifetime distribution of the depicted cells in the
presence (left population) and in the absence of the acceptor (right
population). (F-J) Gaq-mTqΔ6 intensity image in the presence of
acceptor YFP-Gg2 and histamine 1 receptor (H1R) (F) before and (G) after
addition of histamine. Phase lifetime image of Gaq-mTqΔ6 (H) before
and (I) after addition of histamine. (J) Phase lifetime histogram; lifetime
distribution of the depicted cells (left) before and (right) after addition of
histamine. (K-O) Gaq-mTqΔ6 intensity image in the presence of acceptor
YFP-Gg2 and the guanine nucleotide exchange factor p63-RhoGEF (K)
before and (L) after addition of histamine. Phase lifetime image of Gaq-
mTqΔ6 (M) before and (N) after addition of histamine. (O) Phase lifetime
histogram; lifetime distribution of the depicted cells (left) before and
(right) after addition of histamine.
Additional File 10: PtdIns(4,5)P2 hydrolysis upon hypotonic stimulus
(A) Green fluorescent protein (GFP)-PH was used as an indicator for
PtdIns(4,5)P2 levels, and was found to be localized predominantly at the
plasma membrane of HeLa cells. (C) Membrane localization was
quantified by means of a line profile plot. Upon applying the hypotonic
stimulus (B) the PH domain translocated partially to the cytoplasm,
which is also evident from (D) the line profile plot, showing decreased
membrane intensity and increased cytoplasmic intensity.
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